CHARLES M BAUM
CIK 1579824 · Founder, President, and CEO · last filed 2026-06-05
CHARLES M BAUM is a Founder, President, and CEO who has filed 71 SEC Form 4 insider transactions across 5 companies since 2013. The most recent filing, for PMVP, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$47.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $13.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$13.9K
5
71
-$47.82M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PMVP | Director | — | $1.11 | — | $0 | 7 | 2026-06-05 |
| ACRV | Director | 9,366 | $1.48 | $13.9K | $0 | 4 | 2026-05-20 |
| Poseida Therapeutics, Inc. (PSTX) Delisted | Director | 0 | $9.50 | $0 | $0 | 4 | 2025-01-08 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Founder, President, and CEO | 114,482 | $58.70 | $6.72M | -$47.82M | 42 | 2024-01-23 |
| IMMUNOMEDICS INC (IMMU) Delisted | Director | 0 | — | — | $0 | 4 | 2020-10-23 |
Recent Filings
71 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | PMVP | Grant (A) | — | $0 | EDGAR |
| 2026-05-20 | ACRV | Grant (A) | +9,366 | $0 | EDGAR |
| 2025-06-17 | ACRV | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | PMVP | Grant (A) | — | $0 | EDGAR |
| 2025-01-08 | Poseida Therapeutics, Inc. (PSTX) Delisted | Mixed | −78,600 | $0 | EDGAR |
| 2024-06-24 | ACRV | Grant (A) | — | $0 | EDGAR |
| 2024-06-18 | Poseida Therapeutics, Inc. (PSTX) Delisted | Grant (A) | +19,650 | $0 | EDGAR |
| 2024-06-10 | PMVP | Grant (A) | — | $0 | EDGAR |
| 2024-01-23 | Mirati Therapeutics, Inc. (MRTX) Delisted | Disp (D) | −237,871 | $0 | EDGAR |
| 2024-01-03 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +20,425 | $1.20M | EDGAR |